Style | Citing Format |
---|---|
MLA | Ashrafi MR, et al.. "Comparative Efficacy of Risdiplam and Nusinersen in Type 2 and 3 Spinal Muscular Atrophy Patients: A Cohort Study Using Real-World Data." Journal of neuromuscular diseases, vol. 11, no. 6, 2024, pp. 1190-1199. |
APA | Ashrafi MR, Babaee M, Hashemi Nazari SS, Barzegar M, Ghazavi M, Beiraghi Toosi M, Nafissi S, Inaloo S, Zamani Ghaletaki G, Fatehi F, Heshmat R, Ghahvechi Akbari M, Abdi A, Bakhtiary H, Montazerlotfelahi H, Abbaskhanian A, Hosseini SA, Farshadmoghadam H, Hosseiny SMM, ... Jafari N (2024). Comparative Efficacy of Risdiplam and Nusinersen in Type 2 and 3 Spinal Muscular Atrophy Patients: A Cohort Study Using Real-World Data. Journal of neuromuscular diseases, 11(6), 1190-1199. |
Chicago | Ashrafi MR, Babaee M, Hashemi Nazari SS, Barzegar M, Ghazavi M, Beiraghi Toosi M, Nafissi S, et al.. "Comparative Efficacy of Risdiplam and Nusinersen in Type 2 and 3 Spinal Muscular Atrophy Patients: A Cohort Study Using Real-World Data." Journal of neuromuscular diseases 11, no. 6 (2024): 1190-1199. |
Harvard | Ashrafi MR et al. (2024) 'Comparative Efficacy of Risdiplam and Nusinersen in Type 2 and 3 Spinal Muscular Atrophy Patients: A Cohort Study Using Real-World Data', Journal of neuromuscular diseases, 11(6), pp. 1190-1199. |
Vancouver | Ashrafi MR, Babaee M, Hashemi Nazari SS, Barzegar M, Ghazavi M, Beiraghi Toosi M, et al.. Comparative Efficacy of Risdiplam and Nusinersen in Type 2 and 3 Spinal Muscular Atrophy Patients: A Cohort Study Using Real-World Data. Journal of neuromuscular diseases. 2024;11(6):1190-1199. |
BibTex | @article{ author = {Ashrafi MR and Babaee M and Hashemi Nazari SS and Barzegar M and Ghazavi M and Beiraghi Toosi M and Nafissi S and Inaloo S and Zamani Ghaletaki G and Fatehi F and Heshmat R and Ghahvechi Akbari M and Abdi A and Bakhtiary H and Montazerlotfelahi H and Abbaskhanian A and Hosseini SA and Farshadmoghadam H and Hosseiny SMM and Shariatmadari F and Ziaadini B and Babaei M and Tavasoli A and Nikbakht S and Momen A and Khajeh A and Aminzadeh V and Mollamohammadi M and Taghdiri MM and Nasehi MM and Memarian S and Badv RS and Heidari M and Jafari N}, title = {Comparative Efficacy of Risdiplam and Nusinersen in Type 2 and 3 Spinal Muscular Atrophy Patients: A Cohort Study Using Real-World Data}, journal = {Journal of neuromuscular diseases}, volume = {11}, number = {6}, pages = {1190-1199}, year = {2024} } |
RIS | TY - JOUR AU - Ashrafi MR AU - Babaee M AU - Hashemi Nazari SS AU - Barzegar M AU - Ghazavi M AU - Beiraghi Toosi M AU - Nafissi S AU - Inaloo S AU - Zamani Ghaletaki G AU - Fatehi F AU - Heshmat R AU - Ghahvechi Akbari M AU - Abdi A AU - Bakhtiary H AU - Montazerlotfelahi H AU - Abbaskhanian A AU - Hosseini SA AU - Farshadmoghadam H AU - Hosseiny SMM AU - Shariatmadari F AU - Ziaadini B AU - Babaei M AU - Tavasoli A AU - Nikbakht S AU - Momen A AU - Khajeh A AU - Aminzadeh V AU - Mollamohammadi M AU - Taghdiri MM AU - Nasehi MM AU - Memarian S AU - Badv RS AU - Heidari M AU - Jafari N TI - Comparative Efficacy of Risdiplam and Nusinersen in Type 2 and 3 Spinal Muscular Atrophy Patients: A Cohort Study Using Real-World Data JO - Journal of neuromuscular diseases VL - 11 IS - 6 SP - 1190 EP - 1199 PY - 2024 ER - |